Garcia-Rivera, MF, Colvin-Wanshura, LE, Nelson, MS, Nan, Z, Khan, SA, Rogers, TB et al.. Characterization of an immunodeficient mouse model of mucopolysaccharidosis type I suitable for preclinical testing of human stem cell and gene therapy. Brain Res Bull 74: 429-438

Department of Neurosurgery, University of Minnesota, Minneapolis, MN, USA.
Brain Research Bulletin (Impact Factor: 2.72). 12/2007; 74(6):429-38. DOI: 10.1016/j.brainresbull.2007.07.018
Source: PubMed


Mucopolysaccharidosis type I (MPS-I or Hurler syndrome) is an inherited deficiency of the lysosomal glycosaminoglycan (GAG)-degrading enzyme alpha-l-iduronidase (IDUA) in which GAG accumulation causes progressive multi-system dysfunction and death. Early allogeneic hematopoietic stem cell transplantation (HSCT) ameliorates clinical features and extends life but is not available to all patients, and inadequately corrects its most devastating features including mental retardation and skeletal deformities. To test novel therapies, we characterized an immunodeficient MPS-I mouse model less likely to develop immune reactions to transplanted human or gene-corrected cells or secreted IDUA. In the liver, spleen, heart, lung, kidney and brain of NOD/SCID/MPS-I mice IDUA was undetectable, and reduced to half in heterozygotes. MPS-I mice developed marked GAG accumulation (3-38-fold) in these organs. Neuropathological examination showed GM(3) ganglioside accumulation in the striatum, cerebral peduncles, cerebellum and ventral brainstem of MPS-I mice. Urinary GAG excretion (6.5-fold higher in MPS-I mice) provided a non-invasive and reliable method suitable for serially following the biochemical efficacy of therapeutic interventions. We identified and validated using rigorous biostatistical methods, a highly reproducible method for evaluating sensorimotor function and motor skills development. This Rotarod test revealed marked abnormalities in sensorimotor integration involving the cerebellum, striatum, proprioceptive pathways, motor cortex, and in acquisition of motor coordination. NOD/SCID/MPS-I mice exhibit many of the clinical, skeletal, pathological and behavioral abnormalities of human MPS-I, and provide an extremely suitable animal model for assessing the systemic and neurological effects of human stem cell transplantation and gene therapeutic approaches, using the above techniques to measure efficacy.

Download full-text


Available from: Mayra F Garcia-Rivera, Oct 08, 2015
21 Reads
  • Source
    • "We evaluated the phenotype of Idua-W392X mice at three ages and found that mutant mice developed a quantifiable disease progression. We found evidence of biochemical, metabolic, and morphological abnormalities that correlate closely with the phenotype described for other MPS I-H animal models [10] [11] [14] as well with the human MPS I- H disease [2]. Thus, the Idua-W392X mouse will allow us to evaluate the efficacy of therapeutic approaches that previously have been limited by the availability of a suitable MPS I-H animal model. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Here we report the characterization of a knock-in mouse model for the autosomal recessive disorder mucopolysaccharidosis type I-Hurler (MPS I-H), also known as Hurler syndrome. MPS I-H is the most severe form of alpha-l-iduronidase deficiency. alpha-l-iduronidase (encoded by the IDUA gene) is a lysosomal enzyme that participates in the degradation of dermatan sulfate and heparan sulfate. Using gene replacement methodology, a nucleotide change was introduced into the mouse Idua locus that resulted in a nonsense mutation at codon W392. The Idua-W392X mutation is analogous to the human IDUA-W402X mutation commonly found in MPS I-H patients. We found that the phenotype in homozygous Idua-W392X mice closely correlated with the human MPS I-H disease. Homozygous W392X mice showed no detectable alpha-l-iduronidase activity. We observed a defect in GAG degradation as evidenced by an increase in sulfated GAGs excreted in the urine and stored in multiple tissues. Histology and electron microscopy also revealed evidence of GAG storage in all tissues examined. Additional assessment revealed bone abnormalities and altered metabolism within the Idua-W392X mouse. This new mouse will provide an important tool to investigate therapeutic approaches for MPS I-H that cannot be addressed using current MPS I-H animal models.
    Molecular Genetics and Metabolism 08/2009; 99(1):62-71. DOI:10.1016/j.ymgme.2009.08.002 · 2.63 Impact Factor
  • Source
  • [Show abstract] [Hide abstract]
    ABSTRACT: In the future, it is expected that robots will play important roles in coexisting with humans. Whenever humans come into contact with these robots they must be able to adjust their physical softness parameters, which will help humans remain calm and which will be favourable for human emotions. Therefore, it is desirable for robots to control their impedance characteristics in such cases. From these points of view, desirable values of the impedance parameters of robots are investigated in this paper through a rating scale method. In terms of the results, the emotions felt by humans with regard to the robots being soft, pleasant and human-like are explained by a linear regression model of the impedance values, and the emotions of being reassuring are classified into four groups
    Robotics and Automation, 1997. Proceedings., 1997 IEEE International Conference on; 05/1997
Show more